Crossmark

Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT

Crossref DOI link: https://doi.org/10.1038/s41408-025-01233-9

Published Online: 2025-02-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xue, Rongtao

Dai, Min

Jiang, Erlie https://orcid.org/0000-0003-0237-6063
Ou, Xueying

Huang, Fen

Fan, Zhiping

Xu, Na

Yan, Chenhua

Nie, Danian

Liang, Xinquan

Chen, Hong

Ye, Jieyu

Jiang, Ling

Liu, Hui

Jin, Hua

Lin, Ren

Zhang, Yu

Sun, Jing

Han, Mingzhe https://orcid.org/0000-0002-1720-6799
Liu, Qifa https://orcid.org/0000-0003-4015-3952
Wang, Yu https://orcid.org/0000-0003-1253-7465
Xuan, Li https://orcid.org/0000-0002-6176-7411
License Information

Text and Data Mining valid from 2025-02-19

Version of Record valid from 2025-02-19
More Information

Article History

Received: 6 October 2024

Revised: 25 January 2025

Accepted: 12 February 2025

First Online: 19 February 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below